title: Objective response of superficial bladder tumors to intravesical treatment (including review of response of marker lesions).
authors.affiliation: CHU Sart Tilman, Liège, Belgium.
authors.forename: C
authors.initials: C
authors.lastname: Bouffioux
authors.forename: A
authors.initials: A
authors.lastname: van der Meijden
authors.forename: K H
authors.initials: KH
authors.lastname: Kurth
authors.forename: G
authors.initials: G
authors.lastname: Jakse
authors.forename: A
authors.initials: A
authors.lastname: Bono
authors.forename: R
authors.initials: R
authors.lastname: Hall
authors.forename: W
authors.initials: W
authors.lastname: Oosterlinck
authors.forename: R
authors.initials: R
authors.lastname: Sylvester
mesh_terms: D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002278:Carcinoma in Situ / Q000188:drug therapy / Q000473:pathology; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents